Total Funding
89
51
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9452
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
- Michelle Mellion: Chief Medical OfficerPast Role: EveryONE Medicines, Chief Medical Officer
- Jane Rhodes: Chief Executive OfficerPast Role: Verge Genomics, President & Chief Business Officer
About the Company
AstronauTx aims to restore astrocyte homeostasis function as a treatment for dementias. In a healthy brain, astrocytes support neuronal firing, metabolism, and blood-brain barrier function; however, in disease, they can exacerbate and even drive neurotoxicity.
